← Evidence map

TrialClinical cancer research : an official journal of the American Association for Cancer Research2012

Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).

Kim A Margolin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22228638